CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,042 | 132,591 | ||
| 2025-03-28 | Cioffi Christiana Marie Chief Strategy Officer | Grant or award · Restricted Share Unit | +10,000 | 160,000 | ||
| 2025-03-28 | Sayad Pierre Sargis Chief Medical Officer | Grant or award · Restricted Share Unit | +10,000 | 160,000 | ||
| 2025-03-28 | Evans Terry L Chief Commercial Officer | Grant or award · Restricted Share Unit | +10,000 | 160,000 | ||
| 2025-03-28 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Restricted Share Unit | +75,000 | 475,000 | ||
| 2025-03-28 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Stock Options | +50,000 | 525,000 | ||
| 2025-03-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award · Restricted Share Unit | +75,000 | 827,722 | ||
| 2025-03-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award · Stock Options | +50,000 | 877,722 | ||
| 2025-03-28 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Restricted Share Unit | +75,000 | 75,000 | ||
| 2025-03-28 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Stock Options | +50,000 | 450,000 | ||
| 2025-03-28 | Evans Terry L Chief Commercial Officer | Grant or award · Restricted Share Unit | +10,000 | 10,000 | ||
| 2025-03-28 | Cioffi Christiana Marie Chief Strategy Officer | Grant or award · Restricted Share Unit | +10,000 | 10,000 | ||
| 2025-03-05 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $6.79 | $68K | 68,725 |
| 2025-02-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,042 | 131,549 | ||
| 2025-02-28 | Raykov Rosty Director | Grant or award | +2,431 | 78,725 | ||
| 2025-02-14 | RALLIS CHRIS A Director | Option exercise 10b5-1 | +1,992 | $2.51 | $5K | 54,206 |
| 2025-02-14 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,186 | $6.82 | $8K | 53,020 |
| 2025-02-14 | RALLIS CHRIS A Director | Option exercise · Common Shares 10b5-1 | −1,992 | $2.51 | $5K | 182,706 |
| 2025-02-05 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $6.66 | $67K | 76,294 |
| 2025-01-31 | Raykov Rosty Director | Grant or award | +2,431 | 86,294 |
Page 10 of 17 · 340 trades